Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Arthritis | Research

The regional disparities in liver disease comorbidity among elderly Chinese based on a health ecological model: the China Health and Retirement Longitudinal Study

Authors: Wei Gong, Hong Lin, Xiuting Ma, Hongliang Ma, Yali Lan, Peng Sun, Jianjun Yang

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Purpose

This study aimed to investigate the risk factors for liver disease comorbidity among older adults in eastern, central, and western China, and explored binary, ternary and quaternary co-morbid co-causal patterns of liver disease within a health ecological model.

Method

Basic information from 9,763 older adults was analyzed using data from the China Health and Retirement Longitudinal Study (CHARLS). LASSO regression was employed to identify significant predictors in eastern, central, and western China. Patterns of liver disease comorbidity were studied using association rules, and spatial distribution was analyzed using a geographic information system. Furthermore, binary, ternary, and quaternary network diagrams were constructed to illustrate the relationships between liver disease comorbidity and co-causes.

Results

Among the 9,763 elderly adults studied, 536 were found to have liver disease comorbidity, with binary or ternary comorbidity being the most prevalent. Provinces with a high prevalence of liver disease comorbidity were primarily concentrated in Inner Mongolia, Sichuan, and Henan. The most common comorbidity patterns identified were "liver-heart-metabolic", "liver-kidney", "liver-lung", and "liver-stomach-arthritic". In the eastern region, important combination patterns included "liver disease-metabolic disease", "liver disease-stomach disease", and "liver disease-arthritis", with the main influencing factors being sleep duration of less than 6 h, frequent drinking, female, and daily activity capability. In the central region, common combination patterns included "liver disease-heart disease", "liver disease-metabolic disease", and "liver disease-kidney disease", with the main influencing factors being an education level of primary school or below, marriage, having medical insurance, exercise, and no disabilities. In the western region, the main comorbidity patterns were "liver disease-chronic lung disease", "liver disease-stomach disease", "liver disease-heart disease", and "liver disease-arthritis", with the main influencing factors being general or poor health satisfaction, general or poor health condition, severe pain, and no disabilities.

Conclusion

The comorbidities associated with liver disease exhibit specific clustering patterns at both the overall and local levels. By analyzing the comorbidity patterns of liver diseases in different regions and establishing co-morbid co-causal patterns, this study offers a new perspective and scientific basis for the prevention and treatment of liver diseases.
Appendix
Available only for authorised users
Literature
1.
Xia M, Sun X, Zheng L, Bi Y, Li Q, Sun L, Di F, Li H, Zhu D, Gao Y, et al. Regional difference in the susceptibility of non-alcoholic fatty liver disease in China. BMJ Open Diabetes Res Care. 2020;8(1):e001311.
2.
Koutnikova H, Genser B, Monteiro-Sepulveda M, Faurie JM, Rizkalla S, Schrezenmeir J, Clément K. Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2019;9(3):e017995.PubMedPubMedCentralCrossRef
3.
Newton KP, Wilson LA, Crimmins NA, Fishbein MH, Molleston JP, Xanthakos SA, Behling C, Schwimmer JB. Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2023;21(5):1261–70.PubMedCrossRef
4.
Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J, et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(1):20–30.PubMedCrossRef
5.
Spagnuolo R, Abenavoli L, Corea A, Larussa T, Mancina RM, Cosco C, Luzza F, Doldo P. Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review. Eur Rev Med Pharmacol Sci. 2021;25(18):5818–25.PubMed
6.
7.
Faner R, Cruz T, López-Giraldo A, Agustí A. Network medicine, multimorbidity and the lung in the elderly. Eur Respir J. 2014;44(3):775–88.PubMedCrossRef
8.
Qiu H, Wang L, Zeng X, Pan J. Comorbidity patterns in depression: A disease network analysis using regional hospital discharge records. J Affect Disord. 2022;296:418–27.PubMedCrossRef
9.
Li X, Liu G, Chen W, Bi Z, Liang H. Network analysis of autistic disease comorbidities in Chinese children based on ICD-10 codes. BMC Med Inform Decis Mak. 2020;20(1):268.PubMedPubMedCentralCrossRef
10.
Alexander-Bloch AF, Raznahan A, Shinohara RT, Mathias SR, Bathulapalli H, Bhalla IP, Goulet JL, Satterthwaite TD, Bassett DS, Glahn DC, et al. The architecture of co-morbidity networks of physical and mental health conditions in military veterans. Proc Math Phys Eng Sci. 2020;476(2239):20190790.PubMedPubMedCentral
11.
Mu XM, Wang W, Wu FY, Jiang YY, Ma LL, Feng J. Comorbidity in Older Patients Hospitalized with Cancer in Northeast China based on Hospital Discharge Data. Int J Environ Res Public Health. 2020;17(21):8028.
12.
Zhou D, Wang L, Ding S, Shen M, Qiu H. Phenotypic Disease Network Analysis to Identify Comorbidity Patterns in Hospitalized Patients with Ischemic Heart Disease Using Large-Scale Administrative Data. Healthcare (Basel). 2022;10(1):80.PubMedPubMedCentralCrossRef
13.
Chen Y, Shi L, Zheng X, Yang J, Xue Y, Xiao S, Xue B, Zhang J, Li X, Lin H, et al. Patterns and Determinants of Multimorbidity in Older Adults: Study in Health-Ecological Perspective. Int J Environ Res Public Health 2022;19(24):16756.
14.
Roso-Llorach A, Vetrano DL, Trevisan C, Fernández S, Guisado-Clavero M, Carrasco-Ribelles LA, Fratiglioni L, Violán C, Calderón-Larrañaga A. 12-year evolution of multimorbidity patterns among older adults based on Hidden Markov Models. Aging (Albany NY). 2022;14(24):9805–17.PubMedCrossRef
15.
Vetrano DL, Damiano C, Tazzeo C, Zucchelli A, Marengoni A, Luo H, Zazzara MB, van Hout H, Onder G. Multimorbidity Patterns and 5-Year Mortality in Institutionalized Older Adults. J Am Med Dir Assoc. 2022;23(8):1389-1395.e1384.PubMedCrossRef
16.
Nguyen QD, Wu C, Odden MC, Kim DH. Multimorbidity Patterns, Frailty, and Survival in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2019;74(8):1265–70.PubMedCrossRef
17.
Mino-León D, Reyes-Morales H, Doubova SV, Pérez-Cuevas R, Giraldo-Rodríguez L, Agudelo-Botero M. Multimorbidity Patterns in Older Adults: An Approach to the Complex Interrelationships Among Chronic Diseases. Arch Med Res. 2017;48(1):121–7.PubMedCrossRef
18.
Fan J, Sun Z, Yu C, Guo Y, Pei P, Yang L, Chen Y, Du H, Sun D, Pang Y, et al. Multimorbidity patterns and association with mortality in 0.5 million Chinese adults. Chin Med J (Engl). 2022;135(6):648–57.PubMedCrossRef
19.
Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, Sweeting M, Muller D, Romieu I, Bazelle P, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020;18(1):5.PubMedPubMedCentralCrossRef
20.
Sturmer J, Franken DL, Ternus DL, Henn RL, Soares Dias-da-Costa J, Anselmo Olinto MT, Vieira Paniz VM. Dietary patterns and prevalence of multimorbidity in women in southern Brazil. Menopause. 2022;29(9):1047–54.PubMedCrossRef
21.
Tazzeo C, Rizzuto D, Calderón-Larrañaga A, Roso-Llorach A, Marengoni A, Welmer AK, Onder G, Trevisan C, Vetrano DL. Multimorbidity patterns and risk of frailty in older community-dwelling adults: a population-based cohort study. Age Ageing. 2021;50(6):2183–91.PubMedPubMedCentralCrossRef
22.
Yao SS, Cao GY, Han L, Chen ZS, Huang ZT, Gong P, Hu Y, Xu B. Prevalence and Patterns of Multimorbidity in a Nationally Representative Sample of Older Chinese: Results From the China Health and Retirement Longitudinal Study. J Gerontol A Biol Sci Med Sci. 2020;75(10):1974–80.PubMedCrossRef
23.
Zhong Y, Qin G, Xi H, Cai D, Wang Y, Wang T, Gao Y. Prevalence, patterns of multimorbidity and associations with health care utilization among middle-aged and older people in China. BMC Public Health. 2023;23(1):537.PubMedPubMedCentralCrossRef
24.
Marengoni A, Rizzuto D, Wang HX, Winblad B, Fratiglioni L. Patterns of chronic multimorbidity in the elderly population. J Am Geriatr Soc. 2009;57(2):225–30.PubMedCrossRef
25.
Mu XM, Wang W, Jiang YY, Feng J. Patterns of Comorbidity in Hepatocellular Carcinoma: A Network Perspective. Int J Environ Res Public Health. 2020;17(9):3108.
26.
Feng J, Mu XM, Ma LL, Wang W. Comorbidity Patterns of Older Lung Cancer Patients in Northeast China: An Association Rules Analysis Based on Electronic Medical Records. Int J Environ Res Public Health. 2020;17(23):9119.
27.
Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation Am Fam Physician. 2006;74(5):756–62.PubMed
28.
Zeng J, Lai X, Wang S, Zeng D, Ye J, Huang C, Liu M, Zhang W, Xu H. Association of depressive symptoms with chronic liver disease among middle-aged and older adults in China. Front Psychiatry. 2023;14:1273754.PubMedPubMedCentralCrossRef
29.
Ma Y, An K, Zhang K, Deng H, Deng R, Su Q. Exploring disease interrelationships in older inpatients: a single-centre, retrospective study. Front Public Health. 2023;11:1110014.PubMedPubMedCentralCrossRef
30.
Zhao YW, Haregu TN, He L, Lu S, Katar A, Wang H, Yao Z, Zhang L. The effect of multimorbidity on functional limitations and depression amongst middle-aged and older population in China: a nationwide longitudinal study. Age Ageing. 2021;50(1):190–7.PubMedCrossRef
31.
Collin C, Wade D, Davies S, Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud. 1988;10(2):61–3.PubMedCrossRef
32.
Britt HC, Harrison CM, Miller GC, Knox SA. Prevalence and patterns of multimorbidity in Australia. Med J Aust. 2008;189(2):72–7.PubMedCrossRef
33.
Chen H, Mui AC. Factorial validity of the Center for Epidemiologic Studies Depression Scale short form in older population in China. Int Psychogeriatr. 2014;26(1):49–57.PubMedCrossRef
34.
Wang H, Li G, Tsai C-L. Regression coefficient and autoregressive order shrinkage and selection via the lasso. J R Stat Soc Ser B Stat Methodol. 2007;69(1):63–78.CrossRef
35.
Marill KA. Advanced Statistics: Linear Regression, Part II: Multiple Linear Regression. Acad Emerg Med. 2004;11(1):94–102.PubMedCrossRef
36.
Bastian M, Heymann S, Jacomy M. Gephi: An Open Source Software for Exploring and Manipulating Networks. Proceedings of the International AAAI Conference on Web and Social Media. 2009;3(1):361–2.CrossRef
37.
Zulu LC, Kalipeni E, Johannes E. Analyzing spatial clustering and the spatiotemporal nature and trends of HIV/AIDS prevalence using GIS: the case of Malawi, 1994–2010. BMC Infect Dis. 2014;14:285.PubMedPubMedCentralCrossRef
38.
Osaki Y, Taniguchi S, Tahara A, Okamoto M, Kishimoto T. Metabolic syndrome and incidence of liver and breast cancers in Japan. Cancer Epidemiol. 2012;36(2):141–7.PubMedCrossRef
39.
Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009;115(24):5651–61.PubMedCrossRef
40.
Arroyo V. The liver and the kidney: mutual clearance or mixed intoxication. Contrib Nephrol. 2007;156:17–23.PubMedCrossRef
41.
Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–18.PubMedCrossRef
42.
43.
Matyas C, Haskó G, Liaudet L, Trojnar E, Pacher P. Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nat Rev Cardiol. 2021;18(2):117–35.PubMedCrossRef
44.
Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.PubMedPubMedCentralCrossRef
45.
El Hadi H, Di Vincenzo A, Vettor R, Rossato M. Relationship between Heart Disease and Liver Disease: A Two-Way Street. Cells. 2020;9(3):567.
46.
Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand? World J Gastroenterol. 2019;25(28):3684–703.PubMedPubMedCentralCrossRef
47.
Ahmed O, Robinson MW, O’Farrelly C. Inflammatory processes in the liver: divergent roles in homeostasis and pathology. Cell Mol Immunol. 2021;18(6):1375–86.PubMedPubMedCentralCrossRef
48.
Spagnolo P, Zeuzem S, Richeldi L, du Bois RM. The complex interrelationships between chronic lung and liver disease: a review. J Viral Hepat. 2010;17(6):381–90.PubMedCrossRef
49.
Soulaidopoulos S, Goulis I, Cholongitas E. Pulmonary manifestations of chronic liver disease: a comprehensive review. Ann Gastroenterol. 2020;33(3):237–49.PubMedPubMedCentral
50.
Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–32.PubMedPubMedCentralCrossRef
51.
Podgórska J, Werel P, Klapaczyński J, Orzechowska D, Wudarski M, Gietka A. Liver involvement in rheumatic diseases. Reumatologia. 2020;58(5):289–96.PubMedPubMedCentralCrossRef
52.
Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut–liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol. 2023;20(7):447–61.PubMedCrossRef
53.
de la Fuente RA. Nutrition and Chronic Liver Disease. Clin Drug Investig. 2022;42(Suppl 1):55–61.CrossRef
54.
Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516–37.PubMedCrossRef
55.
Kardashian A, Serper M, Terrault N, Nephew LD. Health disparities in chronic liver disease. Hepatology. 2023;77(4):1382–403.PubMedCrossRef
56.
Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci. 2021;22(10):5170.
57.
Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L, Sheron N. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. J Hepatol. 2018;69(3):718–35.PubMedCrossRef
58.
Ruan X, Chen J, Sun Y, Zhang Y, Zhao J, Wang X, Li X, Yuan S, Larsson SC. Depression and 24 gastrointestinal diseases: a Mendelian randomization study. Transl Psychiatry. 2023;13(1):146.PubMedPubMedCentralCrossRef
59.
Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–92.PubMedCrossRef
60.
Pan XF, Pan A. Dietary transitions and cardiometabolic health in China. Lancet Diabetes Endocrinol. 2019;7(7):502–3.PubMedCrossRef
61.
Deane KD, Demoruelle MK, Kelmenson LB, Kuhn KA, Norris JM, Holers VM. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31(1):3–18.PubMedPubMedCentralCrossRef
62.
Zhou Y, Wang J, Duan Y, Luo X, Wan Z, Luo Y, Li Y, Wang Y, Xie J. Dietary diversity and determinants of young adults in central China: A cross-sectional study from 2015 to 2020. Front Nutr. 2022;9:931107.PubMedPubMedCentralCrossRef
63.
Guo J, Fei Y, Li J, Zhang L, Luo Q, Chen G. Gender- and age-specific associations between sleep duration and prevalent hypertension in middle-aged and elderly Chinese: a cross-sectional study from CHARLS 2011–2012. BMJ Open. 2016;6(9):e011770.PubMedPubMedCentralCrossRef
64.
Wang Q, Shen JJ, Frakes K. Limited contribution of health behaviours to expanding income-related chronic disease disparities based on a nationwide cross-sectional study in China. Sci Rep. 2018;8(1):12485.PubMedPubMedCentralCrossRef
65.
Chimed-Ochir O, Delgermaa V, Takahashi K, Purev O, Sarankhuu A, Fujino Y, Bayarmagnai N, Dugee O, Erkhembayar R, Lkhagvaa B, et al. Mongolia health situation: based on the Global Burden of Disease Study 2019. BMC Public Health. 2022;22(1):5.PubMedPubMedCentralCrossRef
66.
67.
Lin L, Bai S, Qin K, Wong CKH, Wu T, Chen D, Lu C, Chen W, Guo VY. Comorbid depression and obesity, and its transition on the risk of functional disability among middle-aged and older Chinese: a cohort study. BMC Geriatr. 2022;22(1):275.PubMedPubMedCentralCrossRef
68.
Jiang CH, Zhu F, Qin TT. Relationships between Chronic Diseases and Depression among Middle-aged and Elderly People in China: A Prospective Study from CHARLS. Curr Med Sci. 2020;40(5):858–70.PubMedCrossRef
69.
Korolainen MA, Tuominen S, Kurki S, Lassenius MI, Toppila I, Purmonen T, Santaholma J, Nissilä M. Burden of migraine in Finland: multimorbidity and phenotypic disease networks in occupational healthcare. J Headache Pain. 2020;21(1):8.PubMedPubMedCentralCrossRef
Metadata
Title
The regional disparities in liver disease comorbidity among elderly Chinese based on a health ecological model: the China Health and Retirement Longitudinal Study
Authors
Wei Gong
Hong Lin
Xiuting Ma
Hongliang Ma
Yali Lan
Peng Sun
Jianjun Yang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18494-x

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue

Research

Effects of Wuxi CDC WeChat official account article features on user engagement in health promotion

Research

Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis

Research

Effectiveness of human immunodeficiency virus prevention strategies by mapping the geographic dispersion pattern of human immunodeficiency virus prevalence in Nanning, China

Research

Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030

Research

Assessment of the correlation between KAP scores regarding sugar-sweetened beverage consumption and hyperuricemia amongst Chinese young adults

Research

Assessment of the integrated disease surveillance and response system implementation in health zones at risk for viral hemorrhagic fever outbreaks in North Kivu, Democratic Republic of the Congo, following a major Ebola outbreak, 2021